You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Trio of COVID-19 treatments receive NICE nod

The National Institute for Health and Care Excellence’s (NICE’s) final draft guidance has recommended three COVID-19 treatments as options for adults. They are Pfizer’s Paxlovid, GSK’s Xevudy and Roche’s RoActemra.